<i>PRKDC</i>: new biomarker and drug target for checkpoint blockade immunotherapy
2020 · Journal for ImmunoTherapy of Cancer · 59 citations
https://doi.org/10.1136/jitc-2019-000485
Y
Yu‐Chan Chang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
172
Papers
3.5K
Citations
36
h-index
75
i10-index
Yu‐Chan Chang is an academic researcher from National Yang Ming Chiao Tung University. The author has contributed to research in topics: Cancer, Hypoxia, and Metabolism & RNA modifications and cancer & Cholangiocarcinoma and Gallbladder Cancer Studies. The author has an h-index of 36, co-authored 147 publications.
ORCID: 0000-0003-0474-9935Papers by this author
worksGlucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axis
2017 · Journal of Hematology & Oncology · 57 citations
https://doi.org/10.1186/s13045-016-0372-0
Parathyroid Hormone-Like Hormone is a Poor Prognosis Marker of Head and Neck Cancer and Promotes Cell Growth via RUNX2 Regulation
2017 · Scientific Reports · 52 citations
https://doi.org/10.1038/srep41131
Squalene synthase promotes the invasion of lung cancer cells via the osteopontin/ERK pathway
2020 · Oncogenesis · 47 citations
https://doi.org/10.1038/s41389-020-00262-2
Metabolic protein phosphoglycerate kinase 1 confers lung cancer migration by directly binding HIV Tat specific factor 1
2021 · Cell Death Discovery · 38 citations
https://doi.org/10.1038/s41420-021-00520-1
Type V collagen alpha 1 chain promotes the malignancy of glioblastoma through PPRC1-ESM1 axis activation and extracellular matrix remodeling
2021 · Cell Death Discovery · 37 citations
https://doi.org/10.1038/s41420-021-00661-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat